Everspin 10-Q: Q3 Revenue Up 47% to $20.6M, but BIS Penalty Exposure Hits $11.2M
MRAM sits 65% above its 52-week low of $7.35.
Summary
Everspin's Q3 revenue rose 46.9% to $20.6 million, but litigation and a $2.7 million BIS export-control accrual drove a $7.2 million net loss; BIS is seeking up to about $11.2 million.
Key Events · Earnings and Guidance · MRAM
-
Q3 Revenue Jumps 46.9% to $20.6M
Total revenue rose to $20.6 million from $14.1 million a year earlier. Product sales were up 33.5% to $16.9 million, while licensing and engineering services climbed 170.3% to $3.7 million.
-
Net Loss of $7.2M on Legal Costs
The Q3 net loss was $7.2 million, or $0.29 per share, versus $54 thousand of net income a year ago. G&A rose 253.1% to $13.0 million, including $6.0 million of patent litigation costs and a $2.7 million regulatory accrual.
-
BIS Seeks Up to $11.2M Penalty
BIS has proposed a civil penalty of approximately $11.2 million for export-control violations. Everspin accrued $2.7 million and countered at $2.7 million, leaving roughly $8.5 million of unaccrued exposure if BIS prevails.
-
$41.4M Engineering Agreements Backlog
Three engineering services agreements totaling $41.4 million were signed. Of that, $6.8 million has been recognized, with $34.6 million remaining to be recognized through 2027 and 2028.
Analysis · MRAM · Manufacturing
The revenue growth is real: Q3 sales rose 46.9% to $20.6 million and gross margin held at 51.4%. But the quarter swung to a $7.2 million net loss, driven by general and administrative costs that jumped 253.1% to $13.0 million on $6.0 million of patent litigation costs plus a $2.7 million accrual for the BIS export-control matter. That BIS accrual is the number that matters. The company booked its own $2.7 million settlement counteroffer, while BIS is asserting a penalty of approximately $11.2 million, so an adverse outcome could cost roughly $8.5 million more than reserved. Cash fell only modestly, to $43.0 million from $44.5 million at year-end, and management says that is enough for the next 12 months, so this is a legal-cost problem rather than a liquidity crisis. What underpins the growth story is the $41.4 million of new engineering services agreements, with $34.6 million still to be recognized through 2027-2028.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MRAM was trading at $12.13 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $299.1M. The 52-week trading range was $7.35 to $51.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.